Dr. Yoshimitsu Kobayashi
President and CEO
Dr. Yoshimitsu Kobayashi has been President and CEO of Mitsubishi Chemical Holdings Corporation since 2007.
Dr. Kobayashi graduated from University of Tokyo, Japan in 1969, after which he studied Radiation Physics at Hebrew University of Jerusalem, Israel and Chemical Reactions at Scuola Normale Superiore in Pisa, Italy, as a government-sponsored scholar. Finally in 1975, he received a PhD in radiation physics from University of Tokyo, Japan.
Prior to his current role, Dr. Kobayashi, who joined Mitsubishi Chemical Corp. in 1974, was General Manager of Storage Media Department from 1996 to 2005, and was Chief Technology Officer from 2005 to 2007.
Spotlight on Mitsubishi Chemical Holdings Corporation
Mitsubishi Chemical Holdings Corporation (MCHC) was established in October 2005 as the holding company of two operating companies, Mitsubishi Chemical Corporation (MCC) and Mitsubishi Pharma Corporation. In October 2007, Mitsubishi Pharma Corporation merged with Tanabe Seiyaku Company, Limited forming Mitsubishi Tanabe Pharma Corporation (MTPC). In April 2008, Mitsubishi Plastic, Incorporated (MPI), which had been an affiliate company of MCC, joined the MCHC Group as the third core operating company, merging MCC's four businesses in functional products. And, in April 2010, MCHC acquired Mitsubishi Rayon Company, Limited (MRC) through TOB.
The MCHC Group has a wide range of businesses in three domains such as functional products, health care and materials. At the end of March 2010, the MCHC Group comprised 345 consolidated companies and 76 equity-method affiliates, employing a total of 53,907 people around the world. The total turnover of MCHC Group now amounts to approximately 40 billion dollars annually.
In keeping with the Group philosophy of "Good Chemistry for Tomorrow - Creating better relationships among people, society, and our planet," MCHC makes full use of its three decision criteria for corporate activities - Sustainability, Health and Comfort - in its mid-term management plan, "APTSIS 15" (2011 - 2015). This initiative aims to optimize strategic investments while transforming its business portfolio to ensure high profitability, sustainable growth and global leadership in each of its industries.
MCHC highlights Lithium-ion battery (LIB) materials as one of its Growth Businesses in "APTSIS 15". LIB market has been expanding very rapidly for automobile and household applications. The MCHC Group is the only manufacturer capable of producing all four key materials - electrolytes, anodes, cathodes, and separators.
Chemical components for automobiles are also very important business in the MCHC Group. Lightweight materials for vehicle bodies are important technologies for realizing improvements in fuel efficiency, heat management, and reductions in exhaust gas emissions. The MCHC Group is engaged in the development of high performance plastic composites and carbon fiber composites that can be applied as glazing, exterior panels, and structural components that replace metal and glass.
Through "APTSIS 15", MCHC is committed to running its business in a way that delivers "KAITEKI" (which traditionally means "comfort" or "ease" in Japanese) solutions by putting the infinite potential of "Good Chemistry" to work.